| Name | RCGD423 |
|---|---|
| Synonyms |
2-Thiazolamine, N-(4-bromophenyl)-4-phenyl-
N-(4-Bromophenyl)-4-phenyl-1,3-thiazol-2-amine |
| Description | RCGD423 is a gp130 modulator, which prevents articular cartilage degeneration and promotes repair. |
|---|---|
| Related Catalog | |
| Target |
gp130[1] |
| In Vitro | RCGD423 is a gp130 modulator, which prevents articular cartilage degeneration and promotes repair[1]. |
| In Vivo | RCGD423 greatly reduces chondrocyte hypertrophy, loss and degeneration while increasing chondrocyte proliferation beyond that observed in response to injury in a rat partial meniscectomy model. Moreover, RCGD 423 improves cartilage healing in a rat full-thickness osteochondral defect model, increasing proliferation of mesenchymal cells in the defect and also inhibiting breakdown of cartilage matrix in de novo generated cartilage[1]. |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 465.6±47.0 °C at 760 mmHg |
| Molecular Formula | C15H11BrN2S |
| Molecular Weight | 331.230 |
| Flash Point | 235.4±29.3 °C |
| Exact Mass | 329.982635 |
| LogP | 5.25 |
| Vapour Pressure | 0.0±1.2 mmHg at 25°C |
| Index of Refraction | 1.695 |
| Storage condition | 2-8℃ |